Company Active LTD

Company profile

Emblation Limited

UK company SC346874, incorporated on 11 August 2008.

Emblation

Emblation Limited is a UK company with status Active founded in 2008 based in Scotland.

Company number
SC346874
Incorporated
11 Aug 2008
Companies House status
Active

Company identity

Founded / incorporated
11 August 2008

Company number SC346874

Verify at Companies House
Legal name
EMBLATION LIMITED
Company type
Private Limited Company
Region
Scotland
Registered address
EMBLATION HOUSE
CASTLE BUSINESS PARK
STIRLING
SCOTLAND
FK9 4TS
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

5 events
14 Feb
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

31 Jan
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

11 Aug
2008

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2017
Funded years
2017, 2020
Age at first award
8 years

Projects

2020 Feasibility Studies Lead participant

AVAC: Anti Viral Air Conditioning

1 Jun 2020 to 31 Mar 2021

Awarded
£49,853
Total cost £49,853

Emblation Ltd would like to repurpose the microwave generators it has to create a prototype air filtration system that renders viral particles in air inactive. In order to validate the prototype works, a test rig will be designed and manufactured to fit into a class II biosafety cabinet. Existing filtration methods do not destroy the virus particles but t...

2020 Collaborative R&D Lead participant

CAIRN -a miniaturized microwave medical device

1 Mar 2020 to 28 Feb 2022

Awarded
£349,545
Total cost £515,694

Emblation is an established manufacturer of microwave medical devices and wishes to shrink the volume of one of its products to a handheld device and make a step reduction in its cost of goods. With a smaller and cheaper device, adoption rates will increase and new markets can be addressed. ArQana Technologies is an experienced designer and supplier of mi...

2017 Feasibility Studies Lead participant

Microwave treatment for anogenital disease (MiTAG)

1 Sep 2017 to 31 Aug 2018

Awarded
£82,312
Total cost £117,588

The primary objective of the project is to explore the feasibility of a new treatment for cervical precancerous disease and genital warts by designing new applicators and repurposing an existing product used to treat verrucas. All three diseases are caused by infection with human papillomaviruses (HPV) but differ in the exact type of HPV involved. The obj...

2017 Collaborative R&D Lead participant

MTAK - Microwave Therapy for Actinic Keratosis

1 Aug 2017 to 30 Apr 2019

Awarded
£144,243
Total cost £206,062

It is estimated that 1 in 3 people over 60 years old in the UK has at least one actinic keratosis (AK) lesion. Actinic keratoses are the first appearance of a non-melanoma skin cancer. With a deficit of more than 200 dermatologists in the UK, the ability to diagnose and treat is being diminished. Up to 25% of GP workload is skin based and with an ageing p...

Product types

Collaborative R&D Feasibility Studies